Knowledge Exchange by ISID

Monkeypox: A Global Health Emergency
  • Speakers: Prof. Dimie Ogoina, M.D and Dr. David Hamer
  • Facilitated by: Teresa L. Schraeder, M.D. (USA)
  • August 3, 2022

Learning Objectives:

  • Learn more about the latest surge of cases of Monkeypox
  • Listen to discussion about the history of this DNA zoonotic virus
  • Understand why public health officials are worried and the knowns/unknowns about this global emergency 
  • Hear analysis of problems with diagnosis, control, treatment, and prevention in different parts of the world
Emerging Leader Podcast Series Episode 2: IPC During a Public Health Emergency
  • Speaker: Dr. Bassem Zayed (Jordan)
  • Moderators: Dr. Enrique Castro-Sanchez (United Kingdom) and Dr. Angel Desai (USA)

In this podcast, ISID Emerging Leaders Enrique Castro-Sanchez and Angel Desai speak with Dr. Bassem Zayed, Medical Officer, Infection Prevention and Control at the World Health Organization regarding challenges encountered during public health and humanitarian emergencies.

MDR Organisms in the ICU
  • Speaker: Anucha Apisarnthanarak, Professor, Thammasat University Hospital (Thailand)
  • Facilitated by: Teresa L. Schraeder, M.D. (USA)
  • July 12, 2022

MDR Organisms in the ICU

  • MDR organisms of most concern in the ICU
  • Pressures driving MDR in Thailand and elsewhere
  • How Covid-19 impacted MDR 
  • Message about MDR from Asia 
AMR Challenges: An MIS-C COVID-19 Patient in a LMIC
  • Faculty: Shirani Chandrasiri (Sri Lanka), Esmita Charani (UK), Duminda Samarasinghe (Sri Lanka), Seif Al-Abri (Oman)
  • June 21, 2022

This session will review some of the AMR challenges faced in low- and middle-income countries. The increase in resistance of microbes to antimicrobials is outpaced by the development of effective and safe antimicrobial agents. AMR has both health and economic impacts, particularly in low- and middle-income countries. In low resource settings, there is low availability and high costs of some of the laboratory tests routinely conducted in high income countries to manage AMR. The case we shall present addresses Multisystem Inflammatory Syndrome in Children (MIS-C) which has been reported worldwide with temporal association with COVID-19. MIS-C is a post-infectious multi-organ inflammatory consequence of such infection. It is a heterogeneous disease entity where prominent cardiovascular complications, particularly myocardial and coronary artery involvement is recognized.

This webinar is supported with an Unrestricted Educational Grant from bioMérieux.
COVID-19: Pandemic or Endemic
  • Speaker: Professor Raina MacIntyre (Australia)
  • May 5, 2022

COVID-19 eradication is unlikely. During the pandemic, as vaccination programs began nearly everywhere, herd immunity was suggested as the outcome to control SARS CoV-2 replication and dissemination. However today, as we are facing waning vaccine efficacy, new variants of the virus with different pathogenic patterns, scientists and public health authorities are suggesting the pandemic is over and that we are in an endemic phase. Raina MacIntyre explains why this is not so, and that SARS-CoV-2 will continue to cause epidemics and likely a substantial burden of chronic disease. Better control will improve these outcomes.


To achieve this, a vaccine-PLUS strategy is needed, with layered protections including testing, tracing, safe indoor air and masks. Vaccine equity globally must also be addressed.

Writing for Successful Publication
  • Speaker: Professor Shui Shan Lee (Hong Kong)
  • Facilitated by: Teresa L. Schraeder, M.D. (USA)
  • June 23, 2022

Learning Objectives:


  • Review fundamentals of writing including grammar, syntax, and structure
  • Advice on the best use of graphics, illustrations, and photographs for publication
  • Discuss submission and use of early drafts of articles, open access, and impact factors
  • Learn specifics of selecting the right journal, preparing for submission, and following author guidelines
  • Gain knowledge of best practices for reviews, revisions, and rebuttals
This professional development workshop is funded by the Bill & Melinda Gates Foundation.
Emerging Leader Podcast Series Episode 1: Antimicrobial Stewardship
  • Chairs: Dr. Afreenish Amir (Pakistan), Associate Professor David Moore (South Africa)
  • Speaker: Professor Olga Perovic (South Africa)
  • May 13, 2022

This podcast covers important aspects of AMR surveillance including the prevalence of drug resistant infections, what constitutes an AMR surveillance team and the importance of  surveillance for understanding the burden of AMR and informing its solutions.

Vaccine Inequity in the Global South
  • Speaker: Fatima Hassan, Founder, Health Justice Initiative, South Africa
  • Facilitated by: Teresa L. Schraeder, M.D. (USA)
  • Producer: Amador (Tino) Delamerced, BA (USA)
  • May 1, 2022

Three billion people worldwide have not received a single dose of Covid-19 vaccine. While the majority of citizens in several wealthy countries are fully vaccinated, low- and middle-resourced countries have the lowest rates of vaccination. The average vaccination rate of all African countries is 15 percent. Some countries on the African continent have only single digit vaccination rates and only a minority of their health care workers are fully vaccinated. The World Health Organization has pushed to prioritize first doses for the unvaccinated before extra boosters for wealthy countries.


Fatima Hassan, human rights lawyer and activist, is the director of the Health Justice Initiative in South Africa. She is working to increase access to vaccinations, testing, and treatment for all countries with a particular emphasis on the southern hemisphere.

Antimicrobial Stewardship without a Microbiology Lab
  • Speakers: Professor Sade Ogunsola (Nigeria), Professor Andrew Whitelaw (South Africa), Dr. Winnie Nambatya (Uganda), Dr. Ibrahim Mugerwa (Uganda)
  • Facilitated by: Teresa L. Schraeder, M.D. (USA)
  • Producer: Amador (Tino) Delamerced, BA (USA)
  • April 8, 2022

In this podcast, you will: 

  • Review the global threat of antimicrobial resistance
  • Learn about antimicrobial stewardship in low- and moderate-resourced countries
  • Evaluate importance of microbiology labs in clinical settings
  • Review obstacles and solutions for antibiotic stewardship programs in various countries
We found no results for your search. Please change or remove at least one filter to broaden your search.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies